Kristen Taylor Meadows

Company: Gossamer Bio

Job title: Senior Director, Biology

Seminars:

Investigating GB7208: An Oral, CNS-Penetrant, Irreversible BTK inhibitor for the Treatment of Neuroinflammatory Diseases 4:00 pm

Learn how BTK inhibitors are actively being explored in inflammatory diseases Discover how they are characterized by modest selectivity and/or limited central nervous system (CNS) penetrance Assess GB7208, an orally available, selective, irreversible small molecule BTK inhibitor which has been selected based on its potency, specificity, and high brain penetrance in preclinical modelsRead more

day: Day One